Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.

Buse DC, Serrano D, Reed ML, Kori SH, Cunanan CM, Adams AM, Lipton RB.

Headache. 2015 Jun;55(6):825-39. doi: 10.1111/head.12556. Epub 2015 Apr 17.

PMID:
25881857
2.

Dihydroergotamine and sumatriptan in isolated human coronary artery, middle meningeal artery and saphenous vein.

Labruijere S, Chan KY, de Vries R, van den Bogaerdt AJ, Dirven CM, Danser AJ, Kori SH, MaassenVanDenBrink A.

Cephalalgia. 2015 Feb;35(2):182-9. doi: 10.1177/0333102414544977. Epub 2014 Jul 30.

PMID:
25078720
3.

Treatment persistence and switching in triptan users: a systematic literature review.

Messali AJ, Yang M, Gillard P, Tsai K, Tepper SJ, Bloudek LM, Kori SH.

Headache. 2014 Jul-Aug;54(7):1120-30. doi: 10.1111/head.12404. Epub 2014 Jun 10. Review.

PMID:
24912394
4.

Effects of switching acute treatment on disability in migraine patients using triptans.

Serrano D, Buse DC, Kori SH, Papapetropoulos S, Cunanan CM, Manack AN, Reed ML, Lipton RB.

Headache. 2013 Oct;53(9):1415-29. doi: 10.1111/head.12164. Epub 2013 Jun 28.

PMID:
23808937
5.

Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine.

Silberstein SD, Kori SH.

CNS Drugs. 2013 May;27(5):385-94. doi: 10.1007/s40263-013-0061-2. Review.

PMID:
23620146
6.

Gastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications.

Aurora SK, Papapetropoulos S, Kori SH, Kedar A, Abell TL.

Cephalalgia. 2013 Apr;33(6):408-15. doi: 10.1177/0333102412473371. Epub 2013 Mar 5. Review.

7.

Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia.

Tepper SJ, Kori SH, Borland SW, Wang MH, Hu B, Mathew NT, Silberstein SD.

Headache. 2012 Jan;52(1):37-47. doi: 10.1111/j.1526-4610.2011.02041.x. Epub 2011 Nov 22.

PMID:
22106843
8.

MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments.

Tepper SJ, Kori SH, Goadsby PJ, Winner PK, Wang MH, Silberstein SD, Cutrer FM.

Mayo Clin Proc. 2011 Oct;86(10):948-55. doi: 10.4065/mcp.2011.0093. Erratum in: Mayo Clin Proc. 2011 Dec;86(12):1248.

9.

MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.

Aurora SK, Silberstein SD, Kori SH, Tepper SJ, Borland SW, Wang M, Dodick DW.

Headache. 2011 Apr;51(4):507-17. doi: 10.1111/j.1526-4610.2011.01869.x.

PMID:
21457235
10.

A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.

Aurora SK, Rozen TD, Kori SH, Shrewsbury SB.

Headache. 2009 Jun;49(6):826-37. doi: 10.1111/j.1526-4610.2009.01453.x.

PMID:
19545249
11.

Medullary pain facilitating neurons mediate allodynia in headache-related pain.

Edelmayer RM, Vanderah TW, Majuta L, Zhang ET, Fioravanti B, De Felice M, Chichorro JG, Ossipov MH, King T, Lai J, Kori SH, Nelsen AC, Cannon KE, Heinricher MM, Porreca F.

Ann Neurol. 2009 Feb;65(2):184-93. doi: 10.1002/ana.21537.

12.

Randomized, double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of MAP0004 (orally-inhaled DHE) in adult asthmatics.

Shrewsbury SB, Kori SH, Miller SD, Pedinoff A, Weinstein S.

Curr Med Res Opin. 2008 Jul;24(7):1977-85. doi: 10.1185/03007990802160677 . Epub 2008 Jun 4.

PMID:
18534051
13.

Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial--a comment.

Derosier FJ, Kori SH.

Headache. 2007 Apr;47(4):623; author reply 623-5. No abstract available.

PMID:
17445117
14.

Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine.

Winner P, Cady RK, Ruoff GE, Frishberg BM, Alexander WJ, Zhang Y, Kori SH, Lener SE.

Mayo Clin Proc. 2007 Jan;82(1):61-8.

PMID:
17285787
15.

Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attack.

Aurora SK, Kori SH, Barrodale P, McDonald SA, Haseley D.

Headache. 2006 Jan;46(1):57-63.

PMID:
16412152
16.

Ischemic colitis associated with naratriptan and oral contraceptive use: a response.

Malone TD, Kori SH.

Headache. 2005 Nov-Dec;45(10):1418-9; author reply 1419-20. No abstract available.

PMID:
16324179
17.

Pharmacokinetic opportunities for combination therapy in migraine.

Fox AW, Kori SH.

Neurology. 2005 May 24;64(10 Suppl 2):S21-5. Review. No abstract available.

PMID:
15911783
18.

Management of Bone Pain Secondary to Metastatic Disease.

Kori SH, LaPerriere JA, Kowalski MB, Rodriguez C, Dinwoodie W.

Cancer Control. 1997 Mar;4(2):153-157. No abstract available.

PMID:
10763013
19.

Diagnosis and management of brachial plexus lesions in cancer patients.

Kori SH.

Oncology (Williston Park). 1995 Aug;9(8):756-60; discussion 765. Review.

20.

Interventional neurology: a subspecialty whose time has come.

Kori SH.

Neurology. 1993 Nov;43(11):2395-9. Review. No abstract available.

PMID:
8232967

Supplemental Content

Support Center